← Research Library
Human StudiesDouble-Blind, RCTJournal of Exercise Nutrition and Biochemistry Β· 2019

Purified Shilajit Resin Increases Skeletal Muscle ATP Levels in Healthy Humans

Authors: Das A, Datta S.

Study DesignDouble-Blind, RCT
Cohort Size60 subjects
Duration56 days

Study Background & Rationale

The objective of this randomized, double-blind, placebo-controlled clinical trial was to evaluate the physiological impact of oral administration of purified Himalayan shilajit on skeletal muscle ATP levels and tissue recovery following strenuous physical workouts in healthy, active human subjects.

Intervention Protocol

Daily oral administration of 500 mg purified shilajit extract or an identical placebo capsule for 8 weeks.

Key Academic Findings

  • 01.A statistically significant preservation of muscle ATP concentrations in the active shilajit group following exhausting treadmill exercise.
  • 02.Significant reduction in post-workout plasma lactate levels, indicating delayed anaerobic threshold transitions.
  • 03.Excellent tolerability parameters; zero reported instances of adverse biochemical changes or digestive distress.

πŸ“Š Primary Outcome

Significant retention of muscle ATP levels and reduced markers of exercise-induced muscle fatigue compared to placebo.

πŸ”¬ Understanding the Evidence

These clinical findings suggest that standardized purified shilajit supports mitochondrial respiration efficiency, helping preserve skeletal muscle ATP during high-demand workloads.

Detailed Analysis

Himalayan shilajit has been valued for thousands of years as a metabolic rejuvenator, but until recently, the evidence supporting its benefits was primarily traditional and observational. While Ayurvedic texts described shilajit as a restorer of physical stamina, modern sports science requires objective, quantifiable measurements of cellular bioenergetics.

To bridge this gap, clinical researchers initiated a double-blind, randomized, placebo-controlled trial to evaluate how oral supplementation with purified shilajit resin affects actual energy reserves in human skeletal muscle tissue.

This research explainer provides a detailed breakdown of the study design, measurement methodology, bioenergetic outcomes, and clinical limitations of this trial.


1. Study Design & Participant Criteria

The study utilized a randomized, double-blind, placebo-controlled design over an 8-week (56-day) intervention period.

Participant Profiles

The trial enrolled sixty healthy, recreationally active adult volunteers (aged 21 to 45) who met the following inclusion criteria:

  • Normal body mass index (BMI 18.5–24.9)
  • Engaging in moderate physical exercise 2 to 3 times weekly
  • No use of performance-enhancing supplements (creatine, beta-alanine, high-dose amino acids) within 3 months prior to the trial
  • No history of cardiovascular, renal, metabolic, or thyroid disorders

Selecting a healthy, active but untrained population is clinically relevant. Unlike elite athletes (whose physiological adaptations are highly specialized), recreationally active subjects provide a representative baseline for measuring the metabolic impact of cellular interventions.

The Intervention

Participants were randomly assigned to one of two groups:

  1. The Active Group (30 subjects): Received 500 mg of standardized, purified shilajit extract daily (taken as two 250 mg capsules, morning and afternoon).
  2. The Control Group (30 subjects): Received an identical placebo capsule containing microcrystalline cellulose.

2. Measurement Methodology

To measure the cellular bioenergetic impact of shilajit, researchers combined exercise testing with plasma biomarker monitoring:

The Exhaustive Exercise Challenge

At baseline (Day 0) and at the end of the trial (Day 56), participants performed an exhausting treadmill workout. The treadmill protocol utilized a progressive incline and speed increase designed to drive participants to physical exhaustion within 20 to 30 minutes, pushing cells to their anaerobic limits.

Plasma Biomarker Monitoring

Immediately prior to the workout, immediately post-exhaustion, and 30 minutes into recovery, researchers drew blood samples to monitor key markers of metabolic stress:

  • Adenosine Triphosphate (ATP) Retention: Estimated via cellular recovery assays.
  • Lactate Accumulation: Plasma lactate was monitored to determine the anaerobic threshold transition - the point at which mitochondria can no longer process pyruvate fast enough, forcing cells to shift to lactate-producing glycolysis.
  • Hydroxyproline and Creatine Kinase: Monitored as markers of muscle connective tissue and membrane damage.

3. Primary Outcomes & Findings

The study demonstrated statistically significant differences in physical performance and metabolic recovery markers for the active shilajit group compared to the placebo group at Day 56.

       Post-Workout Plasma Lactate Levels (Day 56)
β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚Active Group: 4.8 mmol/L (lower anaerobic load)β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚Placebo Group: 6.7 mmol/L (higher fatigue)   β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

Key Statistical Results

Lactate Clearance and Anaerobic Delay:

  • The active shilajit group showed a statistically significant reduction in post-workout plasma lactate levels (4.8 mmol/L vs. 6.7 mmol/L in the placebo group).
  • This indicates that shilajit-supplemented muscle fibers maintained aerobic respiration at higher workloads, delaying the transition into fatigue-inducing anaerobic glycolysis.

Retention of Muscle Strength (ATP Preservation):

  • Muscular strength retention (measured via maximal voluntary contraction post-exercise) was significantly higher in the active shilajit group compared to placebo.
  • The researchers concluded that this retention reflected a preservation of skeletal muscle ATP levels during high-demand physical workloads.

Connective Tissue Protection:

  • The active group showed lower post-workout plasma levels of hydroxyproline (a marker of collagen breakdown in muscle connective tissues), suggesting support for tissue integrity during exercise stress.

4. Understanding the Molecular Mechanism

The metabolic outcomes observed in this trial align with the biochemical properties of shilajit's active fractions:

DBP Electron Carrier Action

As explained in the Himalayan shilajit profile, the dibenzo-alpha-pyrones (DBPs) in shilajit act as mobile electron carriers in the mitochondrial inner membrane:

  • Under strenuous exercise, Complexes I-III of the electron transport chain become overloaded.
  • Auxiliary DBPs step in to shuttle electrons, preventing electron transport chain stalling.
  • This maintains the proton gradient across the inner membrane, allowing ATP Synthase to continue recycling ATP even during oxygen-depleted workloads.

Synergistic CoQ10 Support

The organic compounds in shilajit protect the active reduced form of CoQ10 (ubiquinol), preventing its oxidation and maintaining the cellular pool of active antioxidants. This protects the mitochondrial membrane lipids from the lipid peroxidation that typically occurs during exhaustive exercise.


5. Safety and Tolerability Parameters

Consistent with the safety standards required for HimZen profiles:

  • Liver and Kidney Safety: All biochemical markers (ALT, AST, serum creatinine, blood urea nitrogen) remained within healthy physiological ranges throughout the 56-day study.
  • Zero Adverse Events: No subjects withdrew from the study due to supplement-related adverse effects, and zero instances of gastrointestinal distress or allergic responses were reported.
  • Purification Requirement: The researchers emphasized that the trial used strictly purified, standardized shilajit extract. Consuming raw, unpurified shilajit contains heavy metals and toxins that would produce adverse outcomes.

6. Trial Limitations and Future Research Needs

To maintain editorial transparency, we must outline the limitations of this trial:

  • Indirect ATP Measurement: While muscle strength retention is a validated proxy, direct measurement of muscle ATP levels requires muscle biopsies. This trial did not perform biopsies, relying instead on plasma biomarkers and functional performance tests.
  • Sample Size: Sixty subjects is a moderate cohort. Larger, multi-center trials with 100+ subjects are needed to confirm the generalizability of these performance findings.
  • Active vs. Sedentary Populations: The trial evaluated recreationally active individuals. The impact of shilajit on highly trained elite athletes (who have already maximized mitochondrial density) or sedentary older adults remains to be fully characterized.

This guide is for educational purposes only. Readers should consult qualified healthcare professionals before starting, altering, or combining any supplement routine.

⚠️ Research Integrity Notice

This is a plain-language summary of a published study for educational purposes. It is not a substitute for professional medical advice or direct consultation of the original peer-reviewed paper.

Weekly Wellness Insights

Receive The Wellness Research Digest

Join 45,000+ health-conscious readers. Get one research-backed protocol and a breakdown of the latest studies directly to your inbox every Sunday.

πŸ”’ Zero Spam. Unsubscribe with one click. Direct study citations only.